Fine Mark National Bank & Trust Cyto Dyn Inc. Transaction History
Fine Mark National Bank & Trust
- $2.81 Billion
- Q4 2024
A detailed history of Fine Mark National Bank & Trust transactions in Cyto Dyn Inc. stock. As of the latest transaction made, Fine Mark National Bank & Trust holds 15,000 shares of CYDY stock, worth $4,650. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$4,650% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding CYDY
# of Institutions
10Shares Held
275KCall Options Held
0Put Options Held
0-
Diversified Trust CO45.8KShares$14,1940.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY45KShares$13,9500.0% of portfolio
-
Virtue Capital Management, LLC Brentwood, TN45KShares$13,9500.0% of portfolio
-
Rfp Financial Group LLC Atlanta, GA41.5KShares$12,8490.0% of portfolio
-
Next Capital Management LLC32.5KShares$10,0750.0% of portfolio
About CytoDyn Inc.
- Ticker CYDY
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 813,040,000
- Market Cap $252M
- Description
- CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...